172 related articles for article (PubMed ID: 18959179)
21. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications.
Anttila VJ; Elonen E; Nordling S; Sivonen A; Ruutu T; Ruutu P
Clin Infect Dis; 1997 Mar; 24(3):375-80. PubMed ID: 9114188
[TBL] [Abstract][Full Text] [Related]
22. [Favorable Outcome of Hepatosplenic Candidiasis in a Patient with Acute Leukemia].
Čolović N; Arsenijević VA; Suvajdžić N; Djunić I; Tomin D
Srp Arh Celok Lek; 2015; 143(5-6):341-5. PubMed ID: 26259411
[TBL] [Abstract][Full Text] [Related]
23. MR imaging of hepatosplenic candidiasis superimposed on hemochromatosis.
Cho JS; Kim EE; Varma DG; Wallace S
J Comput Assist Tomogr; 1990; 14(5):774-6. PubMed ID: 2398158
[No Abstract] [Full Text] [Related]
24. Hepatic and splenic mycosis in children with acute leukemia.
Moroni C; Castagnola E; Callea F; Lanino E; Rizzo A; Savioli C; Taccone A; Tomà P; Viscoli C
Haematologica; 1991; 76(4):327-9. PubMed ID: 1794740
[TBL] [Abstract][Full Text] [Related]
25. Double invasive fungal infection and typhlitis in children with acute lymphoblastic leukemia.
Avci Z; Alioglu B; Anuk D; Ozbek OY; Azap OK; Ozbek N
Pediatr Hematol Oncol; 2008 Mar; 25(2):99-106. PubMed ID: 18363175
[TBL] [Abstract][Full Text] [Related]
26. Hepatosplenic candidiasis in patients with acute leukemia: what is the optimum prophylaxis following subsequent chemotherapy.
Dear A
Eur J Haematol; 1994 Mar; 52(3):184-6. PubMed ID: 8168600
[No Abstract] [Full Text] [Related]
27. Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature.
Shkalim-Zemer V; Levi I; Fischer S; Tamary H; Yakobovich J; Avrahami G; Gilad G; Elitzur S; Yaniv I; Elhasid R; Manistersky M; Shalit I
Pediatr Infect Dis J; 2018 Jul; 37(7):686-690. PubMed ID: 29140934
[TBL] [Abstract][Full Text] [Related]
28. [Hepatosplenic candidiasis in patients treated for hemato-oncological disorders].
Zweegman S; Sibinga L; Huijgens PC
Ned Tijdschr Geneeskd; 1994 Jan; 138(1):35-8. PubMed ID: 8289957
[TBL] [Abstract][Full Text] [Related]
29. Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging.
Semelka RC; Shoenut JP; Greenberg HM; Bow EJ
J Magn Reson Imaging; 1992; 2(3):341-5. PubMed ID: 1627870
[TBL] [Abstract][Full Text] [Related]
30. Hepatosplenic candidiasis in children with cancer. Three cases in leukemic children and a literature review.
Carstensen H; Widding E; Storm K; Ostergaard E; Herlin T
Pediatr Hematol Oncol; 1990; 7(1):3-12. PubMed ID: 2204407
[TBL] [Abstract][Full Text] [Related]
31. Imprint cytology of hepatosplenic suppurative candidal granuloma complicating acute leukaemia: three case reports.
Kojima M; Kashiwabara K; Itoh H; Masawa N; Miyawaki S
Diagn Cytopathol; 2009 Sep; 37(9):705-6. PubMed ID: 19582806
[No Abstract] [Full Text] [Related]
32. The diagnosis of hepatosplenic candidiasis by DNA analysis of tissue biopsy and serum.
Kirby A; Chapman C; Hassan C; Burnie J
J Clin Pathol; 2004 Jul; 57(7):764-5. PubMed ID: 15220373
[TBL] [Abstract][Full Text] [Related]
33. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study.
Sallah S; Wan JY; Nguyen NP; Vos P; Sigounas G
Cancer; 2001 Sep; 92(6):1349-53. PubMed ID: 11745210
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation.
Björkholm M; Kållberg N; Grimfors G; Eklund LH; Eksborg S; Juneskans OT; Udén AM
J Intern Med; 1991 Aug; 230(2):173-7. PubMed ID: 1865169
[TBL] [Abstract][Full Text] [Related]
35. [Hepatic candidiasis in patients with acute myelogenous leukemia].
Han JK; Kim SH
Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):239-41. PubMed ID: 14558572
[No Abstract] [Full Text] [Related]
36. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.
Anaissie E; Bodey GP; Kantarjian H; David C; Barnett K; Bow E; Defelice R; Downs N; File T; Karam G
Am J Med; 1991 Aug; 91(2):142-50. PubMed ID: 1867240
[TBL] [Abstract][Full Text] [Related]
37. Successful initial treatment with caspofungin alone for hepatosplenic candidiasis in a patient with acute myeloblastic leukemia.
Altintas A; Ayyildiz O; Isikdogan A; Atay E; Kaplan MA
Saudi Med J; 2006 Sep; 27(9):1423-4. PubMed ID: 16951789
[No Abstract] [Full Text] [Related]
38. High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia.
Woolley I; Curtis D; Szer J; Fairley C; Vujovic O; Ugoni A; Spelman D
Leuk Lymphoma; 1997 Nov; 27(5-6):469-74. PubMed ID: 9477128
[TBL] [Abstract][Full Text] [Related]
39. Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis.
Sallah S; Semelka RC; Sallah W; Vainright JR; Philips DL
Leuk Res; 1999 Nov; 23(11):995-9. PubMed ID: 10576503
[TBL] [Abstract][Full Text] [Related]
40. Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia.
Lee DG; Choi JH; Kim YJ; Lee S; Min CK; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Int J Hematol; 2001 Jan; 73(1):119-21. PubMed ID: 11372747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
